Inspire Medical Systems Inc

Inspire Medical Systems, Inc. engages in the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea. It offers inspire therapy, which consists of a remote control and implantable components that includes pressure sensing lead, a neurostimulator, and a stimulation lead. The company was founded by Timothy P. Herbert in November 2007 and is headquartered in Golden Valley, MN.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Inspire Medical Systems achieves first profitable quarter, eyes international growth

Inspire Medical Systems reported a strong performance in Q4 2022, achieving its first profitable quarter and significant revenue growth. The company's focus on enhancing patient outcomes, expanding internationally, and optimizing operational efficiency positions it for continued success.
While challenges with the supply chain were addressed, the company needs to remain vigilant in managing disruptions and addressing analyst concerns to ensure sustained growth. Opportunities in product demand, market expansion, and operational enhancements offer avenues for further development.
Overall, Inspire Medical Systems' strategic initiatives, strong financial performance, and commitment to innovation indicate a positive outlook for future growth and market expansion. The company's focus on driving utilization, improving patient outcomes, and maintaining operational efficiency bodes well for its long-term success.

Inspire Medical Systems Inc reports stellar Q1 performance and eyes global growth opportunities

Inspire Medical Systems Inc delivered robust financial results in Q1 2023, driven by revenue growth and international expansion.
The company's strategic focus on innovation, customer engagement, and therapy adoption positions it well for future success.
Challenges in competition, operational efficiency, and market dynamics require careful navigation, but opportunities for growth and innovation abound.
Overall, Inspire's performance reflects a company poised for continued expansion and impact in the medical technology sector.

Inspire Medical Systems reports robust Q2 growth and eyes global expansion

Inspire Medical Systems delivered strong financial performance in Q2, with revenue growth and margin improvement.
The company's strategic focus on expanding globally, enhancing operational efficiency, and product innovation positions it for future success.
While facing challenges in managing expenses and market mix, Inspire Medical Systems is well-positioned to capitalize on growth opportunities.
Overall, the company's performance, strengths, and strategic initiatives indicate a positive outlook for future growth and market expansion.

Inspire Medical Systems achieves record patient milestone and revenue growth

Inspire Medical Systems reported strong performance in Q3 2023, with notable revenue growth and patient milestones.
Despite challenges with prior authorizations and EU MDR approval delays, the company remains focused on growth and stakeholder value.
Opportunities for expansion with payers and new programs signal a positive outlook for future growth and market reach.
Efforts to streamline processes, educate centers, and drive efficiencies position the company for continued success in the sleep apnea treatment market.

Inspire Medical Systems posts robust Q4 results, eyes global expansion

Inspire Medical Systems reported strong Q4 performance, focusing on growth, profitability, and patient outcomes.
Challenges include market competition, revenue declines in certain regions, and securing reimbursements.
Opportunities lie in expanding utilization rates, market growth in Europe and Asia, and collaborations for increased patient flow.

Inspire Medical Systems Inc reports robust Q1 performance and growth outlook

Inspire Medical Systems Inc's Q1 2024 performance reflects strong revenue growth, improved net loss metrics, and a positive outlook for profitability and revenue expansion in 2024.
The company's strengths lie in its patient-centric approach, innovative product pipeline, and strategic growth initiatives, while challenges include financial performance, competitive landscape, and market penetration.
Opportunities abound in expanding patient qualification, market awareness, and operational efficiency, positioning Inspire for sustained growth and market leadership in the healthcare sector.

Inspire Medical Systems reports strong Q2 performance and growth outlook

Inspire Medical Systems demonstrated robust financial performance, marked by revenue growth and improved profitability.
Strategic initiatives to enhance patient experience and expand market reach position the company for sustained growth.
While facing challenges related to rising expenses, the company's focus on operational efficiency and growth opportunities remains strong.

Inspire Medical Systems reports strong Q3 earnings and growth outlook

Inspire Medical Systems Inc demonstrated robust financial performance in Q3 2024, with revenue and net income showing significant growth.
Despite challenges like revenue headwinds in Q4, the company's focus on innovation and capacity expansion presents growth opportunities.
The upcoming launch of the Inspire V system and efforts to streamline patient access highlight Inspire's commitment to driving future success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

MINNEAPOLIS, April  13, 2020  (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) ("Inspire"), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, today announced preliminary unaudited revenue for the quarter ended March 31, 2020, and the withdrawal of its full year 2020 financial guidance issued on February 25, 2020. In addition, Inspire provided an update on the actions it is taking in response to the ongoing global COVID-19 pandemic.

Inspire Medical Systems, Inc. Provides First Quarter and Full Year 2020 Update

Inspire Medical Systems (INSP) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

Why Inspire Medical Systems (INSP) Stock Might be a Great Pick

Inspire Medical Systems, Inc. (INSP) CEO Tim Herbert on Q4 2019 Results - Earnings Call Transcript

Inspire (INSP) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Why Inspire Medical Systems (INSP) Might Surprise This Earnings Season

Astronics

B&G Foods

Elastic N.V

Freshpet

Northern Oil and Gas

PetMed Express

While the large caps get all the attention, lately, this is more of a negative development than a positive one

8 Stellar Small-Cap Stocks to Buy That Are in Major Industries

MINNEAPOLIS, Feb.  03, 2020  (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea (“OSA”), announced today that three Medicare Administrative Contractors (“MACs”) have announced the effective release date of March 15, 2020, for their final Local Coverage Decision (“LCD”) policies covering Inspire therapy.  In addition, the Wisconsin Physician Services (“WPS”) Government Health Administrators issued their draft LCD proposing coverage of Inspire therapy.

Inspire Medical Systems, Inc. Announces Medicare Policy Release Dates and New Draft Local Coverage Determination for Remaining Region

MINNEAPOLIS, Nov.  20, 2019  (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will be presenting at the 31st Annual Piper Jaffray Healthcare Conference on December 4, 2019 at the Lotte New York Palace Hotel in New York.

Inspire Medical Systems, Inc. to Present at the 31st Annual Piper Jaffray Healthcare Conference

Inspire Medical: The Momentum Continues To Build

Inmode Ltd

Tandem Diabetes Care

Including some of these three top medical-device companies in your portfolio now could be savvy.

3 Fast-Growing Medtech Stocks to Buy

Inspire Medical Systems, Inc. (INSP) CEO Tim Herbert on Q3 2019 Results - Earnings Call Transcript

Inspire (INSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Inspire Medical Systems (INSP) Q3 Earnings Expected to Decline

National Government Services and CGS Administrators, collectively representing 12 states, issue draft policies initiating open public comment period National Government Services and CGS Administrators, collectively representing 12 states, issue draft policies initiating open public comment period

Inspire Medical Systems, Inc. Announces Additional Draft Local Coverage Determinations Proposing Coverage of Inspire Therapy

Inspire Medical Systems offers a niche solution to curing sleep apnea.

Inspire Medical Systems: Huge Potential

CEO and President of Inspire Medical Systems Inc (30-Year Financial, Insider Trades) Timothy P.

Inspire Medical Systems Inc (INSP) CEO and President Timothy P. Herbert Sold $671,900 of Shares

Inspire Medical Systems Inc (INSP) CEO and President Timothy P. Herbert Sold $989,400 of Shares

Fly Leasing

Well-chosen small-cap companies can often provide better returns than their larger counterparts.

3 Top Small-Cap Stocks - to Buy Right Now

Noridian Healthcare Solutions and Palmetto GBA, collectively representing 19 states, issue draft policies initiating open public comment period Noridian Healthcare Solutions and Palmetto GBA, collectively representing 19 states, issue draft policies initiating open public comment period

Inspire Medical Systems, Inc. Announces Draft Local Coverage Determinations Proposing Coverage of Inspire Therapy from Two Regional Medicare Administrators

Company will also Participate in Investor Meetings at Dougherty & Company 2019 Institutional Investor Conference Company will also Participate in Investor Meetings at Dougherty & Company 2019 Institutional Investor Conference

Inspire Medical Systems, Inc. to Present at 2019 Wells Fargo Healthcare Conference

Inspire Medical Systems Inc (INSP) CEO and President Timothy P. Herbert Sold $680,200 of Shares

Inspire Medical Systems Inc (INSP) CEO and President Timothy P. Herbert Sold $1 million of Shares

Inspire makes implantable medical devices that solve an unmet need: patients that are not compliant with CPAP machines.

Sleep Well At Night Investing In Inspire Medical

Inspire Medical Systems Inc (NYSE: INSP) has announced UnitedHealth Group Inc (NYSE: UNH) will cover its Inspire Therapy for the treatment of obstructive sleep apnea beginning Aug.

UnitedHealthcare To Cover Inspire Medical's Sleep Apnea Treatment

Inspire Medical Systems, Inc. (INSP) CEO Tim Herbert on Q1 2019 Results - Earnings Call Transcript

News for Inspire Medical Systems Inc Stock (INSP)